ERBB2 and breast carcinoma: High levels of HER-2 protein expression or HER-2 gene amplification are used to identify patients for whom trastuzumab may be of benefit for treatment of breast cancer in the metastatic or adjuvant disease settings.28 In accordance with the HER-2 testing guidelines, in most laboratories IHC is carried out first with additional testing accomplished by FISH.